| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8242391 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 6 Pages | 
Abstract
												Conclusions: Cancer risk after dose escalation for prostate RT is expected to be equal to or lower than for conventional 3D treatment at 70 Gy, independent of treatment modality or dose-response model. Spot-scanned protons are the treatment of choice for dose escalation because this therapy can halve the risk of secondary cancers.
											Related Topics
												
													Physical Sciences and Engineering
													Physics and Astronomy
													Radiation
												
											Authors
												Uwe Ph.D., Antony Ph.D., Jürgen M.Sc., Peter Ph.D., Norbert M.D., Barbara D.V.M., 
											